0000899243-21-010542.txt : 20210308 0000899243-21-010542.hdr.sgml : 20210308 20210308214149 ACCESSION NUMBER: 0000899243-21-010542 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210304 FILED AS OF DATE: 20210308 DATE AS OF CHANGE: 20210308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KURIYEL RALF CENTRAL INDEX KEY: 0001733143 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 21723944 MAIL ADDRESS: STREET 1: 41 SEYON ST STREET 2: BLDG 1, STE. 100 CITY: WALTHAM STATE: MA ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-04 0 0000730272 REPLIGEN CORP RGEN 0001733143 KURIYEL RALF C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 0 1 0 0 Senior VP, R&D Common Stock 2021-03-04 4 S 0 400 196.23 D 26940 D Common Stock 2021-03-04 4 S 0 25 194.30 D 26915 D Common Stock 2021-03-04 4 S 0 350 192.24 D 26565 D Common Stock 2021-03-04 4 S 0 600 191.20 D 25965 D Common Stock 2021-03-04 4 S 0 700 190.06 D 25265 D Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units. $196.23 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.00 to $196.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $194.30 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.17 to $194.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $192.24 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.20 to $192.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $191.20 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.84 to $191.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $190.06 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.47 to $190.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Jeffrey P. Leduc (Attorney in Fact) 2021-03-08